[Screening for colorectal cancer: even with virtual colography?]

Area of Science:

• Oncology
• Gastroenterology
• Public Health

Background:

• Colorectal cancer (CRC) causes significant mortality and morbidity in Germany, despite being preventable through polyp removal.
• Low uptake of screening colonoscopy necessitates evaluation of alternative screening methods.

Purpose of the Study:

• To review and compare the efficacy and limitations of current colorectal cancer screening tests.
• To inform healthcare providers about available screening options for better patient counseling.

Main Methods:

• Comparative analysis of fecal occult blood tests (guaiac-based and immunochemical).
• Evaluation of virtual colonoscopy (CT and MRI) diagnostic accuracy and limitations.
• Discussion of emerging molecular blood tests for future screening.

Main Results:

• Guaiac-based fecal occult blood tests (gFOBT) have high specificity but low sensitivity (approx. 10%).
• Immunochemical fecal occult blood tests offer higher sensitivity but reduced specificity (approx. 80%).
• Virtual colonoscopy shows 80-90% accuracy for polyps >5mm, but CT faces radiation concerns and MRI lacks widespread validation.

Conclusions:

• No single screening test is perfect; understanding individual test characteristics is vital.
• Physicians must be aware of screening test pros and cons to guide patients effectively.
• Promoting awareness and utilization of diverse screening methods is key to CRC prevention.